Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

171,061-171,120 of 319,975

filter-aware
01
Slide 1
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Setup1 hit
02
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Setup1 hit
03
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Setup1 hit
04
Uses a before-after-bridge style layout to show the merger rationale.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · SetupLoop · Tale Two Worlds1 hit
05
The slide uses a three-column structure to frame the investment thesis: Market Size/Growth, Tailwinds/Complexity, and Product/Geographic Mix.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Executive SummaryLoop · Tale Two Worlds1 hit
06
The slide uses a structured table-like layout to categorize key deal terms.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Executive SummaryLoop · Tale Two Worlds1 hit
07
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Executive SummaryLoop · Tale Two Worlds1 hit
08
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Executive SummaryLoop · Tale Two Worlds1 hit
09
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Executive SummaryLoop · Tale Two Worlds1 hit
10
The slide uses a matrix structure to map product categories (Indicator Testing, Hygiene Monitoring, etc.) against revenue metrics and product types (Consumables vs Hardware/Software).3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
11
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
12
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
13
The diagram uses a hub-and-spoke circular layout to represent an integrated value chain.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
14
Uses a numbered list format to highlight synergy and growth potential.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
15
The slide uses a comparison-style list format to highlight the value proposition of the merger.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key TakeawaysLoop · Before After1 hit
16
The slide uses donut charts to visualize revenue segmentation across three business entities.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
17
The slide uses a logo-grid layout to demonstrate market reach and credibility.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
18
The slide uses a plus sign to indicate the additive nature of the merger.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
19
The slide uses a legend to categorize locations and highlights specific facility expansions in Lansing and Bridgend.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
20
The slide uses a horizontal arrow timeline to represent the progression from pre-signing to post-close.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
21
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
22
The chart uses a stacked bar format to show the contribution of Neogen and 3M Food Safety to total revenue over time.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
23
The slide uses a structured table-like layout to categorize synergies into Growth and Cost buckets, mapping specific initiatives to financial outcomes.3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Propose SolutionLoop · Quick Win Big Bet1 hit
24
3M | Mergers and Acquisitions Presentation Deck | 24 slides3M | Mergers and Acquisitions Presentation Deck | 24 slides · Neogen
Conference presentation Investment bank Beat · Key Takeaways1 hit
01
Slide 1
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
02
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
03
The slide features three photos representing the research team, clinical collaboration, and the patient community.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
04
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
05
The slide uses a structured layout to present three key pillars of clinical success: efficacy, functional outcome, and safety.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
06
The slide uses a process flow diagram to illustrate the clinical trial phases (randomization, treatment, extension).Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
07
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
08
The table displays mean, standard deviation, median, and range for various clinical metrics including Plasma Arginine, GMFCS level, GMFM-E, and 2MWT.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
09
The chart is a box-and-whisker plot comparing pegzilarginase and placebo groups against clinical guidelines and normal ranges.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
10
Clinical trial data showing efficacy of pegzilarginase.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · SolutionLoop · Jobs To Be Done1 hit
11
The slide contrasts unaided mobility assessment (GMFM) with aided mobility assessment (2-Minute Walk Test).Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
12
GMFM-E refers to Gross Motor Function Measure, dimension E (walking, running, jumping).Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
13
The chart shows positive improvement for Pegzilarginase at both time points, while Placebo shows a decline at 12 weeks and slight improvement at 24 weeks.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
14
The slide uses a clear comparison table to demonstrate safety outcomes.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
15
The slide uses a three-part structure to summarize clinical trial outcomes.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Loop · Jobs To Be Done1 hit
16
The slide uses a three-column layout to categorize program strengths.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
17
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
18
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations Beat · AgitateLoop · Cost Of Inaction1 hit
19
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
20
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
21
The slide uses a Gantt-style chart to represent clinical trial phases for different drug programs.Aeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
22
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
23
Aeglea BioTherapeutics | Results Presentation Deck | 23 slidesAeglea BioTherapeutics | Results Presentation Deck | 23 slides · Aeglea BioTherapeutics
Conference presentation Investor relations 1 hit
09
Includes footnotes for data reconciliation and methodology.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
10
The slide uses a waterfall-style bridge to show growth and donut charts for segment composition.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
11
The slide highlights revenue growth and take rate stability post-IPO.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
12
The slide uses bar charts to show growth metrics and highlights key drivers for SG&A and EBITDA changes.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
13
The slide includes a disclaimer note on the right side regarding revenue recognition net of taxes.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
14
The slide uses a waterfall-like logic to explain margin expansion via operating leverage and corporate structure.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · FinancialsLoop · So What Cascade1 hit
15
XP Inc | Results Presentation Deck | 21 slidesXP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
16
XP Inc | Results Presentation Deck | 21 slidesXP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit
17
XP Inc | Results Presentation Deck | 21 slidesXP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit
18
Financial disclosure slide showing non-GAAP adjustments.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit
19
The table uses a waterfall-style logic to subtract columns [B], [C], and [D] from [A] to reach the final adjusted figures.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit
20
Includes YoY and QoQ growth metrics for financial adjustments.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit
21
The slide uses a waterfall-style bridge to show percentage growth between two periods for two distinct business units.XP Inc | Results Presentation Deck | 21 slides · XP Inc.
Conference presentation Investor relations 1 hit